Aios Medical is a pioneering startup on a mission to revolutionize consumer biotech products, aiming to enable every individual to live at least 100 healthy years. With a focus on addressing obesity, the company is enhancing global access to GLP-1 medications through its innovative AI-powered clinical operating system, ClinicOS. This platform facilitates direct-to-patient healthcare for both external brand partners and its own consumer healthcare brands, including Fella Health and Bolt Pharmacy. Since its inception, Aios Medical has experienced exponential growth, serving over 20,000 customers and generating more than $50 million in annual revenue. The company is backed by prominent investors, including Y Combinator and Global Founders Capital, and is committed to serving 100 million patients by 2035, positioning itself to become the world's first trillion-dollar healthcare company.